Besides, naringenin suppressed WT tumor growth in dose-and time-dependent manner in vivo. Western blot found that naringenin inhibited TLR4 expression and p65 phosphorylation in WT xenograft tumors.
Naringenin inhibits WT development viasuppressing TLR4/NF-κB signaling.
Naringenin inhibits WT development viasuppressing TLR4/NF-κB signaling.The quest for strong, safe and cost-effective natural antiproliferative agents that could reduce cancer have been focused now a day. In this regard, the organosulfur compounds from garlic (AlliumsativumL.), like diallyl sulfide (DAS) and diallyl disulfide (DADS), have been shown to exhibit potent antiproliferative and anticancer properties in many studies. However, the potential of these compounds against viral oncoproteins in cervical cancer has not been fully elucidated yet.
The objective of this study was to analyze the antiproliferative and apoptotic properties of DADS and DAS in HPV16+ human cervical cancer Caski cell line.
Caski (cervical cancer cells) were cultured and followed by the treatment of various concentrations of organosulphur compounds (DADS and DAS), cell viability was measured by MTT assay. The apoptotic assay was performed by DAPI and Hoechst3342 staining. Reactive Oxygen Species (ROS) was estimated by DCFDA staining protocol. The distributions of cell cycle and apoptosis (FITC-Annexin V assay) were analyzed by flow cytometry. Finally, gene expression analysis was performed via quantitative real time PCR.
Our results showed that DAS and DADS exerted significant antiproliferative effect on Caski cells by reducing the cell viability and inducing a dose-related increment in intracellular ROS production along with apoptosis in Caski cells. https://www.selleckchem.com/products/Tebipenem-pivoxil(L-084).html DAS and DADS also induced cellcycle arrest in G0/G1 phase, which was supported by the downregulation of cyclin D1 and CDK4 and upregulation of CDK inhibitors p21WAF1/CIP1 and p27KIP1 in Caski cells. Additionally, DAS and DADS lead to downregulation of viral oncogene E6 and E7 and restoration of p53 function.
Thus, this study confirms the efficacy of both the organosulfur compounds DADS and DAS against cervical cancer cells.
Thus, this study confirms the efficacy of both the organosulfur compounds DADS and DAS against cervical cancer cells.Cancer is known to be the second significant cause of death worldwide. Chemotherapeutic agents such as platinum-based compounds are frequently used single-handedly or accompanied with additional chemotherapies to treat cancer patients. Chemotherapy-inducedperipheral painful neuropathy is seen in around 40% of patient who are treated with platinum-based compounds including cisplatin. This not only decreases quality of life of patients but also patients' compliance to cisplatin.
Nalbuphine, an opioid, is frequently used to treat acute and chronic pain coupled with cisplatin in cancer patients. However, long term use of nalbuphine induces tolerance to its analgesic effects. We employed the same strategy to induce tolerance in mice.
Here, we investigated analgesic effects of 2-[(pyrrolidin-1-yl) methyl]-1H-benzimidazole (BNZ), a benzimidazole derivative, on nalbuphine-induced tolerance during cisplatin-induced neuropathic pain using hot plate test, tail flick tests andvon Frey filament in mouse models. Furthermore, we investigated the effects of BNZ on the expression of tumor necrosis factor alpha (TNF-α) in spinal cord.
The results showed that BNZ reduced tolerance to analgesic effects of nalbuphine and TNF-α expression in mice.
BNZ could be potential drug candidate for the management of nalbuphine-induced tolerance in cisplatin-induced neuropathicpain.
BNZ could be potential drug candidate for the management of nalbuphine-induced tolerance in cisplatin-induced neuropathicpain.Heterocyclic compounds, also called heterocycles, are a major class of organic chemicalcompound that plays a vital role in the metabolism of all living cells. The heterocyclic compound, indazole, has attracted more attention in recent years and is widely present in numerous commercially available drugs. Indazole-containing derivatives, representing one of the most important heterocycles in drug molecules, are endowed with a broad range of biological properties.
A literature search was conducted in PubMed, Google Scholar and Web of Science regarding articles related to indazole and its therapeutic application.
The mechanism and structure-activity relationship of indazole and its derivatives were described. Based on their versatile biological activities, the compounds were divided into six groups anti-inflammatory, antibacterial, anti-HIV, antiarrhythmic, antifungal and antitumour. At least 43 indazole-based therapeutic agents were found to be used in clinical application or clinical trials.
This review is a guide for pharmacologists who are in search of valid preclinical/clinical drug compoundswhere the progress of approved marketed drugs containing indazole scaffold is examined from 1966 to the present day. Future direction involves more diverse bioactive moieties with indazole scaffold and greater insights into its mechanism.
This review is a guide for pharmacologists who are in search of valid preclinical/clinical drug compoundswhere the progress of approved marketed drugs containing indazole scaffold is examined from 1966 to the present day. Future direction involves more diverse bioactive moieties with indazole scaffold and greater insights into its mechanism.Schisandronic acid (SA), a triterpenoid from fruits of Schisandra sphenanthera, inhibited pan-genotypic HCV entry into human hepatocytes by interfering with virion-cell membrane fusion. It was a promising lead compound for development of novel HCV entry inhibition agents Objective To search for compounds with more potent anti-HCV and antitumor activities and explore SARs, a series of nov-el derivatives of SA were designed and synthesized and evaluated for in vitro their anti-HCV and antitumor activities.
SA derivatives were synthesized by reduction, condensation, esterification or amidation. The anti-HCV activity of title compounds was tested by inhibition on HCVcc infection of Huh7 cells, and preliminary MOA study was conducted by determining inhibition on HCVpp entry into Huh7 cells. The antitumor activity in vitro was determined by MTT methods.
Totally 24 novel derivatives were synthesized. Most of the compounds inhibited HCVcc infection. Compounds 5hand 6 showed most potent anti-HCVcc activities and inhibition of HCVpp entry into Huh7 cells without obvious cytotoxici-ty.